Suppr超能文献

大鼠体内的肾素-血管紧张素系统与代偿性肾肥大

The renin-angiotensin system and compensatory renal hypertrophy in the rat.

作者信息

Valentin J P, Sechi L A, Griffin C A, Humphreys M H, Schambelan M

机构信息

Department of Medicine, San Francisco General Hospital, University of California San Francisco, 94110, USA.

出版信息

Am J Hypertens. 1997 Apr;10(4 Pt 1):397-402.

PMID:9128205
Abstract

Angiotensin II (Ang II) may act as an angiogenic and growth promoting factor in different tissues. To assess the role of Ang II in compensatory renal growth following unilateral nephrectomy (UNX), we measured renin, angiotensinogen, and Ang II type 1 (AT1) receptor mRNA levels, as well as Ang II receptor density, in two groups of Sprague-Dawley rats 7 days after either sham operation or UNX. Half of each group received either no treatment or an angiotensin-converting enzyme inhibitor (100 mg/dL captopril in the drinking water, initiated at the time of the intervention). Following UNX, the ratio of kidney weight to body weight (KW/BW) in untreated animals was greater than in rats undergoing sham UNX (0.46 +/- 0.01 v 0.37 +/- 0.01%, P < .01). Neither renal renin, nor renal or hepatic angiotensinogen mRNA levels, determined by slot blot hybridization, changed significantly after UNX. Ang II receptor density in glomeruli, determined using an 125I-Sar1-Ile8 Ang II in situ receptor binding assay on frozen kidney sections, did not change significantly after UNX, nor did renal AT1 receptor mRNA. In captopril-treated rats, KW/BW was greater in UNX than in sham operated rats (0.44 +/- 0.01 v 0.37 +/- 0.01%, P < .01), similar to results in untreated animals. Renal and hepatic angiotensinogen mRNA levels were not affected by captopril treatment and did not change further in response to UNX. Captopril treatment increased renin mRNA in both sham operated and UNX rats as compared with untreated controls, but had no significant effect on Ang II receptor density and AT1 receptor mRNA; and no change was observed in either variable as a consequence of UNX. Thus, compensatory renal hypertrophy following UNX occurred in the absence of measurable changes in components of the renin-angiotensin system, and despite functionally significant inhibition of this system by captopril. These data do not support a critical role for Ang II in compensatory renal hypertrophy.

摘要

血管紧张素II(Ang II)可能在不同组织中作为一种血管生成和生长促进因子发挥作用。为了评估Ang II在单侧肾切除术后(UNX)代偿性肾生长中的作用,我们在两组Sprague-Dawley大鼠行假手术或UNX 7天后,测量了肾素、血管紧张素原和血管紧张素II 1型(AT1)受体mRNA水平以及Ang II受体密度。每组一半大鼠不接受任何治疗或接受血管紧张素转换酶抑制剂治疗(饮水中加入100 mg/dL卡托普利,在干预时开始)。UNX后,未治疗动物的肾重与体重之比(KW/BW)高于假手术大鼠(0.46±0.01对0.37±0.01%,P<0.01)。通过狭缝印迹杂交测定,UNX后肾肾素、肾或肝血管紧张素原mRNA水平均无显著变化。使用125I-Sar1-Ile8 Ang II原位受体结合试验在冷冻肾切片上测定肾小球中的Ang II受体密度,UNX后无显著变化,肾AT1受体mRNA也无变化。在卡托普利治疗的大鼠中,UNX组的KW/BW高于假手术组(0.44±0.01对0.37±0.01%,P<0.01),与未治疗动物的结果相似。卡托普利治疗不影响肾和肝血管紧张素原mRNA水平,对UNX也无进一步变化。与未治疗的对照组相比,卡托普利治疗使假手术和UNX大鼠的肾素mRNA均增加,但对Ang II受体密度和AT1受体mRNA无显著影响;UNX后这两个变量均无变化。因此,UNX后的代偿性肾肥大发生在肾素-血管紧张素系统成分无明显变化的情况下,尽管卡托普利对该系统有显著的功能抑制作用。这些数据不支持Ang II在代偿性肾肥大中起关键作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验